MyAverix Finance
SHG · Healthcare
Zhejiang Shengda Pharm (603079)
Drug Manufacturers - Specialty & Generic
Zhejiang Shengda Pharm (603079) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $3.22B, P/E ratio is 50.06, net margin is 7.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603079
Zhejiang Shengda Pharm (603079) — FAQ
What is Zhejiang Shengda Pharm's market cap?
Zhejiang Shengda Pharm (603079) has a reported market cap of $3.22B (data as of 2026-03-28).
What is 603079's P/E ratio?
The price-to-earnings (P/E) ratio for Zhejiang Shengda Pharm (603079) is 50.06 (data as of 2026-03-28).
Does Zhejiang Shengda Pharm pay a dividend?
Dividend yield is not available in the current snapshot for Zhejiang Shengda Pharm (603079). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhejiang Shengda Pharm in?
Zhejiang Shengda Pharm (603079) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603079 listed on?
603079 is listed on SHG.
What is Zhejiang Shengda Pharm's net margin?
Zhejiang Shengda Pharm (603079) reports a net margin of 7.3% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.